Literature DB >> 27336199

Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4'-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein.

Stefano Guglielmo1, Loretta Lazzarato1, Marialessandra Contino2, Maria G Perrone2, Konstantin Chegaev1, Antonio Carrieri2, Roberta Fruttero1, Nicola A Colabufo2,3, Alberto Gasco1.   

Abstract

P-glycoprotein (P-gp) is a well-known membrane transporter expressed in a number of strategic biological barriers, where it exerts a protective effect of paramount importance. Conversely it is one of the main causes of multidrug resistance (MDR), being capable of effluxing many chemotherapeutics. In a development of previous research, a small library of compounds was created conjugating diversely substituted furazan rings with MC70, a well-known P-gp inhibitor. These compounds were assessed for their potency against P-gp and another transporter (MRP1), for their apparent permeability (Papp) and for their ability to induce ATPase activity, thus delineating a complete functional profile. They displayed a substrate mechanism of action and high selectivity toward P-gp, unlike the lead compound. Data relating to their activity range from low micromolar to sub-nanomolar EC50, the most interesting compounds being 15 (0.97 nM), 19 (1.3 nM), 25 (0.60 nM), and 27 (0.90 nM).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27336199     DOI: 10.1021/acs.jmedchem.6b00252

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands.

Authors:  Marialessandra Contino; Stefano Guglielmo; Maria Grazia Perrone; Roberta Giampietro; Barbara Rolando; Antonio Carrieri; Daniele Zaccaria; Konstantin Chegaev; Vanessa Borio; Chiara Riganti; Katarzyna Zabielska-Koczywąs; Nicola A Colabufo; Roberta Fruttero
Journal:  Medchemcomm       Date:  2018-04-03       Impact factor: 3.597

2.  Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer.

Authors:  Yuhong Sun; Xuefei Bao; Yong Ren; Lina Jia; Shenglan Zou; Jian Han; Mengyue Zhao; Mei Han; Hong Li; Qixiang Hua; Yi Fang; Jingyu Yang; Chunfu Wu; Guoliang Chen; Lihui Wang
Journal:  Cell Death Dis       Date:  2019-05-24       Impact factor: 8.469

3.  C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors.

Authors:  Vigneshwaran Namasivayam; Katja Silbermann; Michael Wiese; Jens Pahnke; Sven Marcel Stefan
Journal:  J Med Chem       Date:  2021-03-16       Impact factor: 7.446

4.  New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro.

Authors:  Iris Chiara Salaroglio; Elena Gazzano; Joanna Kopecka; Konstantin Chegaev; Costanzo Costamagna; Roberta Fruttero; Stefano Guglielmo; Chiara Riganti
Journal:  Molecules       Date:  2018-06-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.